What is Hypereosinophilic Syndrome

Hypereosinophilic Syndrome (HES) is a rare blood disorder characterized by the persistent overproduction of eosinophils, a type of white blood cell, leading to inflammation and organ damage. While healthy individuals have low levels of these cells, patients with Hypereosinophilic Syndrome experience levels high enough to infiltrate and impair vital organs, most notably the heart, lungs, skin, and nervous system.

What causes Hypereosinophilic Syndrome?

The pathophysiology of Hypereosinophilic Syndrome involves the body producing an excess of eosinophils (defined as a count greater than 1,500 cells/μL for at least six months) without an identifiable secondary cause like a parasitic infection or allergic reaction. In many cases, this is driven by genetic mutations or abnormal signaling proteins that cause the bone marrow to overproduce these cells, which then release toxic proteins into surrounding tissues.

How is Hypereosinophilic Syndrome classified?

Medical experts generally categorize Hypereosinophilic Syndrome into several distinct clinical subtypes based on the underlying cause:

• Myeloproliferative HES: Often associated with specific genetic mutations (such as the FIP1L1-PDGFRA fusion gene) that cause the bone marrow to act like a low-grade cancer.


• Lymphocytic HES: Triggered by an abnormal population of T-cells that produce cytokines, which in turn stimulate eosinophil production.


• Idiopathic HES: A diagnosis of exclusion when no specific genetic or immune-driven cause can be identified.

Who is typically affected by Hypereosinophilic Syndrome?

Hypereosinophilic Syndrome is extremely rare, though exact prevalence data is limited due to underdiagnosis. It most commonly presents in adults between the ages of 20 and 50. While both men and women can develop Hypereosinophilic Syndrome, certain subtypes, particularly the myeloproliferative form, are more frequently diagnosed in men. There are currently 3 members within the DiseaseMaps.org community who have shared their experiences with this challenging condition.

What differentiates Hypereosinophilic Syndrome from other conditions?

The hallmark that differentiates Hypereosinophilic Syndrome from simple eosinophilia is the presence of documented end-organ damage. Unlike reactive eosinophilia, which resolves when the underlying allergy or infection is treated, Hypereosinophilic Syndrome requires targeted, long-term management to prevent irreversible organ fibrosis or systemic damage.

Next steps

• Consult a hematologist or an immunologist specializing in eosinophilic disorders.


• Discuss genetic testing for mutations like FIP1L1-PDGFRA to determine the best treatment pathway.


• Connect with others by joining the DiseaseMaps.org community to share experiences with fellow patients.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with your healthcare provider for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hypereosinophilic syndrome.


• Orphanet: Hypereosinophilic syndrome (ORPHA:398).


• American Partnership for Eosinophilic Disorders (APFED).


• OMIM (Online Mendelian Inheritance in Man): Entry #607626.